Amersfoort, Netherlands

Chris G Kruse

This inventor holds 1 USPTO granted patent. Top assignee: Solvay Pharmaceuticals, Gmbh. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chris G Kruse. Retrieved from https://idiyas.com/inventor/chris-g-kruse-qrft56yn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chris G Kruse: Innovator in Pharmaceutical Chemistry

Introduction

Chris G Kruse is a notable inventor based in Amersfoort, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential.

Latest Patents

Kruse holds a patent for "Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives," which are compounds exhibiting fibrinogen receptor-antagonistic activity. This innovation is crucial for advancing treatments related to blood coagulation and cardiovascular health.

Career Highlights

Currently, Chris G Kruse is associated with Solvay Pharmaceuticals GmbH, where he continues to engage in groundbreaking research and development. His work has positioned him as a key figure in the pharmaceutical industry, contributing to the advancement of medical science.

Collaborations

Throughout his career, Kruse has collaborated with esteemed colleagues such as Wolfgang Kehrbach and Uwe Schoen. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Chris G Kruse exemplifies the spirit of innovation in pharmaceutical chemistry through his patent and ongoing work at Solvay Pharmaceuticals GmbH. His contributions are vital for the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…